Condition: Prostate Carcinoma · Prostate Neoplasm · Pain Intensity Assessment · Sponsor: Brazilian Institute of Robotic Surgery
The AirSeal platform has been evaluated in urological surgeries, mainly in cases of malignant diseases 5,6. However, there is still a lack of data demonstrating the possible benefits of its use, which justifies the conduct of this research in order to aggregate such knowledge. Therefore, the objective of this prospective pilot study is to compare and evaluate the role of low-pressure pneumoperitoneum with the AirSeal system in patients with prostate cancer undergoing robot-assisted prostatectomy with those undergoing the procedure with the conventional insufflation system. We seek to provide more data on the use of AirSeal, which is associated with shorter operative times, shorter hospital stays and a lower probability of complications. In addition, we aim to ratify the effectiveness and cost-benefit of using the AirSeal system.
This description comes directly from the study's public registry record.
NILO JORGE LEÃO COORDENADOR · +55 71 2626-3030 · ibcrpesquisa@gmail.com
Always discuss trial participation with your own doctor first.
| Instituto Brasileiro de Cirurgia Robotica | Salvador, Estado de Bahia, Brazil | Recruiting |
| Hospital Mater Dei Salvador | Salvador, Estado de Bahia, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06784986